The global fluoxetine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Fluoxetine is used to treat patients with depression, panic attacks, obsessive-compulsive disorder, bulimia disorder, and some form of premenstrual syndrome. This drug improves mood, sleep, appetite, and energy level and restores interest in daily living. The global fluoxetine market is growing due to the increasing prevalence of depression and bipolar disorder patients globally. According to FDA, depression is considered a disabling illness that is expected to lead to suicidal thoughts among people. The off-label recommendation and prescription of anti-depressant and anti-anxiety drugs are driving the growth of the market. The market is also increasing due to the changing lifestyle and increasing societal pressures aid in the high suicidal tendencies, primarily among young adults that leads to depression. According to the World Health Organization 2021, it is estimated that 5% of the world’s adult population suffers from depression.
(Get 15% Discount on Buying this Report)
A full report is available at : https://orionmarketreports.com/global-fluoxetine/92766/
According to World Health Organization 2020, an estimation of 1 million suicides cases was registered due to depression every year. China alone approximately registered 90 million depression patients. Additionally, the research and development of major market players for the manufacturing of generic drugs as a substitute for the branded drug which will be cheaper but equally effective are boosting the growth of the global mirtazapine drug market in the forecast period.
Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape– Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Zydus Group, and Sun Pharmaceutical Industries Ltd. among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are playersaddressing challenges to sustain growth?
- Where is the investment opportunity?
Global Fluoxetine Market Report by Segment
By Type
- 10 Mg
- 20 Mg
By Application
- Depression
- Obsessive compulsive disorder
- Panic disorder
- Bulima Nervosa
- Others
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name : Orion Market Reports
Contact Person : Mr. Anurag Tiwari
Email : Info@orionmarketreports.com
Contact No : +91 780-304-0404
This release has been published on Global market Post
Global market Post is not responsible for any content included in this release.
